Company Overview

Development Stage

About the Company

[Summary] Large-scale pharmaceutical distribution enterprise

China Resources Pharmaceutical Group Limited (stock code: 03320.HK on the Hong Kong Stock Exchange) is a leading comprehensive pharmaceutical company in China, with business covering industrial manufacturing and commercial distribution of pharmaceuticals, health products, and medical devices. Since its listing, we have been included in several major capital market indices, including: Hang Seng Composite MidCap Index, Hang Seng Stock Connect Hong Kong Index, Hang Seng China State-Owned Enterprises Index, Hang Seng Stock Connect China State-Owned Enterprises ESG 40 Index, FTSE Global Equity Index Series, and MSCI China Index, among others.

Our subsidiaries include China Resources Pharmaceutical Commercial Group Co., Ltd., China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ), China Resources Double-Crane Pharmaceutical Co., Ltd. (600062.SH), China Resources Jiangzhong Pharmaceutical Group Co., Ltd. (Jiangzhong Pharmaceutical 600750.SH), Dong-E-E-Jiao Co., Ltd. (000423.SZ), China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ), China Resources Biomedical Pharmaceutical Co., Ltd., Sichuan Nigale Biomedical Technology Co., Ltd., and China Pharmaceutical Research and Development Center Co., Ltd., among others.

In 2024, China Resources Pharmaceutical achieved revenue of RMB 257.67 billion and net profit of RMB 8.40 billion.

The company manufactures 840 products, with a product portfolio including chemical drugs, traditional Chinese medicines, biological preparations, health products, and medical devices, covering a wide range of therapeutic areas, including cardiovascular, gastrointestinal and metabolic diseases, large-volume intravenous infusions, pediatrics, respiratory system, dermatology, as well as blood products, coagulation disorder treatment, and immune disease treatment. We own several renowned brands such as "999", "Dong-E-E-Jiao", "Double-Crane", "Jiangzhong", "Boya Bio", "Zizhu", "Kunzhong Medicine-1381", and "Nigale".

The company's business network covers 28 provinces, autonomous regions, and municipalities directly under the central government across China, with over 270,000 customers, providing highly professional and efficient supply chain services to upstream and downstream customers. In addition, we operate one of the largest retail pharmacy networks in China, with 708 retail pharmacies under our umbrella, of which the total number of DTP pharmacies reaches 270 (including 182 "dual-channel" pharmacies).

"Safeguarding human health and improving quality of life" is our noble mission. In the future, China Resources Pharmaceutical will seize the development and transformation opportunities in China's pharmaceutical and health industry, using R&D innovation and investment and M&A as engines, optimizing resource allocation, consolidating, strengthening, supplementing, and extending the industry chain to drive business development and industrial upgrading, continuously enhance core competitiveness, achieve high-quality development, and strive to become a leading innovative-driven pharmaceutical and health industry enterprise trusted by the public!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

China Resources Pharmaceutical Commercial Products & Services (1 in total)

9.0, 2万 downloads
润药商城是华润医药商业集团旗下的大型医药B2B综合服务平台,致力于为终端客户提供线上采购、物流配送、在线支付、供应链金融等服务,同时为生产厂家和合作伙伴提供在线宣传、品牌推广...
Manage

China Resources Pharmaceutical Commercial How Fast Is Hiring Growing? (562 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 89%
  • 2024: Up 85%
  • 2023: Down 18%
  • 2022: Flat -0%-
China Resources Pharmaceutical Commercial Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
China Resources Pharmaceutical Commercial Campus Recruitment & Advanced Degree Talent Demand
Graduates 3 Interns 7 Master's 5 Doctorate 1
Note: How fast is hiring at China Resources Pharmaceutical Commercial Group Co., Ltd. growing? China Resources Pharmaceutical Commercial2025: 759 openings (up 89%), 2024: 401 openings (up 85%), 2023: 217 openings (down 18%), 2022: 266 openings (flat), 2021: 267 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

China Resources Pharmaceutical Commercial Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 50%
  • 2024: Down 85%
  • 2023: Up 69%
  • 2022: Up 33%
China Resources Pharmaceutical Commercial Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at China Resources Pharmaceutical Commercial Group Co., Ltd. growing? China Resources Pharmaceutical CommercialMaster's recruitment over the years: 2025: 6 openings (up 50%), 2024: 4 openings (down 85%), 2023: 27 openings (up 69%), 2022: 16 openings (up 33%), 2021: 12 openings.

China Resources Pharmaceutical Commercial Doctoral Degree Job Demand Analysis

(More)
-60%
Growth Rate
2026 vs 2025
China Resources Pharmaceutical Commercial Doctoral Hiring by Year: 2026 — 3 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at China Resources Pharmaceutical Commercial Group Co., Ltd. growing? China Resources Pharmaceutical CommercialDoctorate recruitment over the years: 2026: 2 openings (up 67%), 2025: 5 openings (up 50%), 2023: 25 openings (up 69%), 2022: 5 openings (up 33%).

China Resources Pharmaceutical Commercial R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at China Resources Pharmaceutical Commercial Group Co., Ltd.? Based on an analysis of China Resources Pharmaceutical Commercial's job postings over the past year, "计算机/网络/技术类" demand: 35.8%, "医疗卫生/美容保健类": 33.1%, "其他(研发和技术类)": 1.4%, "美术/设计/创意类": 0.4%, "咨询/顾问类": 0.1%, "生物/制药/化工/环保类": 0.1%. For reference only.

China Resources Pharmaceutical Commercial — What Are the Salaries Like? (1158 records)

Manage
China Resources Pharmaceutical Commercial Salary Overview
salary range: 3K - 50K, 65.3% of roles pay ¥10-30K
Note: salary statistics are based on 1158 salary records from the past year and depend on the job sample. For reference only.
How is the salary at China Resources Pharmaceutical Commercial Group Co., Ltd.?China Resources Pharmaceutical Commercial65.3% of positions earn 10-30K, Fresh graduate salary: ¥5.8K。销售类 average salary ¥15.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of China Resources Pharmaceutical Commercial

(More)
Are salaries high at China Resources Pharmaceutical Commercial Group Co., Ltd.? We provide: 信息,销售,运营,副总,财务,地区经理,产品经理,采购,实习生,市场,分析,人力,医疗器械,医药代表,运维,高级经理,ba,药店,大区经理,推广. Click to view detailed salary analysis by job.

China Resources Pharmaceutical Commercial honors, qualifications & industry associations

China Resources Pharmaceutical Commercial Related Industry Tags

Job Category

  • 销售类
    46.7% of total 46.7%
  • 计算机/网络/技术类
    34% of total 34%
  • 医疗卫生/美容保健类
    32.8% of total 32.8%
  • 经营管理类
    22.8% of total 22.8%

Education

  • 本科
    43.6% of total 43.6%
  • 大专
    36.7% of total 36.7%
  • 不限
    17.4% of total 17.4%
  • 高中
    1.4% of total 1.4%

Experience

  • 不限
    29.3% of total 29.3%
  • 1-3年
    28.5% of total 28.5%
  • 3-5年
    21% of total 21%
  • 5-10年
    20.1% of total 20.1%
View Detailed Analysis

What does China Resources Pharmaceutical Commercial Group Co., Ltd. require? Who is China Resources Pharmaceutical Commercial hiring? China Resources Pharmaceutical Commercial recruitment: 销售类占比最多占46.7%,其次是计算机/网络/技术类占34%. What education can get in at China Resources Pharmaceutical Commercial? 本科占比最多占43.6%,其次是大专占36.7%. High education required at China Resources Pharmaceutical Commercial? 硕士占0.8%,博士占0.2%. Work experience required at China Resources Pharmaceutical Commercial? 不限占比最多占29.3%,其次是1-3年占28.5%. Where are the job locations at China Resources Pharmaceutical Commercial? 北京占比最多占42%,其次是成都占5.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 1,964,653.1358万(元)
Legal Representative: 邬建军
Date Established:
Credit Code: 911100007226178547
Registered Address: 北京市东城区安定门内大街257号

China Resources Pharmaceutical Commercial Featured in the Following Albums (More)

Partners & Suppliers

与智翔金泰达成战略合作,作为赛立奇单抗的区域经销商,覆盖医疗终端及零售渠道 Source
供应商 医药流通
作为药品分销商,采购河南晟尔斯生物医药有限公司生产的药品并分销至终端医疗机构 Source
供应商 医药分销/经销商
双方签订年度分销协议,华润医药为复星医药(徐州)提供药品分销服务 Source
供应商 药品分销
华润医药采购立生药业的抗生素产品 Source
供应商 药品商业流通
战略合作,覆盖全国分销网络,重点品种推广。 Source
供应商 医药分销

People who follow China Resources Pharmaceutical Commercial also follow

China Resources Pharmaceutical Commercial Competitors (Similar Companies)

“一家拥有70余年辉煌历史的制药企业”
“Caring for Public Health, Creating a Better Life Together”
“Large pharmaceutical and health industry group”
医药工业 医药
“Although the processing is complicated, we dare not save labor; althou”
“A leader in China's pharmaceutical and healthcare market”
“Committed to righteous success, dedicated to creating value for societ”
阿胶 医药流通 生物制品 心血管药
“Helping partners successfully develop new drugs, reducing R&D costs an”
“A key state-owned backbone enterprise directly managed by the central ”
“Continuously innovating to bring patients medicines that significantly”
“Nature as the source, reshaping you and me”
“Caring for life, safeguarding health”
“People's Post for the People”
医药流通 新特药 大健康 心血管药

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates